Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung

We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topica...

Full description

Saved in:
Bibliographic Details
Main Authors: Vishwanath Sathyanarayanan, Kadabur Nagendrappa Lokesh, Lakshmaiah Kuntejowdahalli Channaviriappa, Linu Abraham Jacob
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2014-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2014;volume=35;issue=1;spage=109;epage=110;aulast=Sathyanarayanan
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849315875606233088
author Vishwanath Sathyanarayanan
Kadabur Nagendrappa Lokesh
Lakshmaiah Kuntejowdahalli Channaviriappa
Linu Abraham Jacob
author_facet Vishwanath Sathyanarayanan
Kadabur Nagendrappa Lokesh
Lakshmaiah Kuntejowdahalli Channaviriappa
Linu Abraham Jacob
author_sort Vishwanath Sathyanarayanan
collection DOAJ
description We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.
format Article
id doaj-art-fce6b88a203d4b9fb948f2b6f5184f21
institution Kabale University
issn 0971-5851
language English
publishDate 2014-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-fce6b88a203d4b9fb948f2b6f5184f212025-08-20T03:52:02ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512014-01-0135110911010.4103/0971-5851.133736Gefitinib-induced skin ulceration in metastatic adenocarcinoma lungVishwanath SathyanarayananKadabur Nagendrappa LokeshLakshmaiah Kuntejowdahalli ChannaviriappaLinu Abraham JacobWe report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2014;volume=35;issue=1;spage=109;epage=110;aulast=SathyanarayananEpidermal growth factor receptorgefitinibskin ulcerationtyrosine kinase inhibitor
spellingShingle Vishwanath Sathyanarayanan
Kadabur Nagendrappa Lokesh
Lakshmaiah Kuntejowdahalli Channaviriappa
Linu Abraham Jacob
Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
Indian Journal of Medical and Paediatric Oncology
Epidermal growth factor receptor
gefitinib
skin ulceration
tyrosine kinase inhibitor
title Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
title_full Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
title_fullStr Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
title_full_unstemmed Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
title_short Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
title_sort gefitinib induced skin ulceration in metastatic adenocarcinoma lung
topic Epidermal growth factor receptor
gefitinib
skin ulceration
tyrosine kinase inhibitor
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2014;volume=35;issue=1;spage=109;epage=110;aulast=Sathyanarayanan
work_keys_str_mv AT vishwanathsathyanarayanan gefitinibinducedskinulcerationinmetastaticadenocarcinomalung
AT kadaburnagendrappalokesh gefitinibinducedskinulcerationinmetastaticadenocarcinomalung
AT lakshmaiahkuntejowdahallichannaviriappa gefitinibinducedskinulcerationinmetastaticadenocarcinomalung
AT linuabrahamjacob gefitinibinducedskinulcerationinmetastaticadenocarcinomalung